Back to Insider Trading View Full Company Profile

RAPP

UNKNOWN

Rapport Therapeutics, Inc.

CIK: 0002012593

Strong Sell (90% confidence)

Last activity: 2 days ago

Financial Metrics

As of Dec 31, 2025 (10-K)

Net Income -$111.48M

Insider Roster (4 total, 4 active)

Insider Buys Sells Net Value Holdings
Ceesay Abraham
Chief Executive Officer
0 12 -$929K
558,528 shares
$16.23M
Bredt David
Chief Scientific Officer
0 8 -$927K
389,275 shares
$11.27M
Yeleswaram Krishnaswamy
Chief Development Officer
0 3 -$401K
286,516 shares
$10.00M
Gault Cheryl
Chief Operating Officer
0 3 -$340K
162,753 shares
$4.56M

Recent Transactions

SELL Yeleswaram Krishnaswamy (Chief Development Officer)

360 shares @ $34.90

$13K

Apr 8, 2026

Conviction: | View SEC Filing →
SELL Gault Cheryl (Chief Operating Officer)

7,161 shares @ $28.04

$201K

Mar 30, 2026

Conviction: | View SEC Filing →
SELL Gault Cheryl (Chief Operating Officer)

2,839 shares @ $28.55

$81K

Mar 30, 2026

Conviction: | View SEC Filing →
SELL Yeleswaram Krishnaswamy (Chief Development Officer)

10,115 shares @ $29.99

$303K

Mar 25, 2026

Conviction: | View SEC Filing →
SELL Gault Cheryl (Chief Operating Officer)

2,014 shares @ $28.93

$58K

Mar 5, 2026

Conviction: | View SEC Filing →
SELL Ceesay Abraham (Chief Executive Officer)

3,552 shares @ $29.05

$103K

Feb 18, 2026

Conviction: | View SEC Filing →
SELL Ceesay Abraham (Chief Executive Officer)

2,983 shares @ $29.04

$87K

Feb 18, 2026

Conviction: | View SEC Filing →
SELL Ceesay Abraham (Chief Executive Officer)

2,281 shares @ $29.80

$68K

Feb 18, 2026

Conviction: | View SEC Filing →
SELL Ceesay Abraham (Chief Executive Officer)

2,100 shares @ $29.80

$63K

Feb 18, 2026

Conviction: | View SEC Filing →
SELL Bredt David (Chief Scientific Officer)

5,400 shares @ $28.95

$156K

Feb 17, 2026

Conviction: | View SEC Filing →
SELL Bredt David (Chief Scientific Officer)

2,200 shares @ $29.59

$65K

Feb 17, 2026

Conviction: | View SEC Filing →
SELL Bredt David (Chief Scientific Officer)

900 shares @ $28.02

$25K

Feb 17, 2026

Conviction: | View SEC Filing →
SELL Ceesay Abraham (Chief Executive Officer)

5,833 shares @ $26.12

$152K

Jan 20, 2026

Conviction: | View SEC Filing →
SELL Ceesay Abraham (Chief Executive Officer)

5,083 shares @ $26.11

$133K

Jan 20, 2026

Conviction: | View SEC Filing →
SELL Bredt David (Chief Scientific Officer)

8,300 shares @ $26.83

$223K

Jan 15, 2026

Conviction: | View SEC Filing →
SELL Bredt David (Chief Scientific Officer)

200 shares @ $27.40

$5K

Jan 15, 2026

Conviction: | View SEC Filing →
SELL Bredt David (Chief Scientific Officer)

6,567 shares @ $30.05

$197K

Dec 31, 2025

Conviction: | View SEC Filing →
SELL Yeleswaram Krishnaswamy (Chief Development Officer)

2,840 shares @ $30.05

$85K

Dec 31, 2025

Conviction: | View SEC Filing →
SELL Ceesay Abraham (Chief Executive Officer)

2,792 shares @ $30.04

$84K

Dec 17, 2025

Conviction: | View SEC Filing →
SELL Ceesay Abraham (Chief Executive Officer)

2,421 shares @ $30.04

$73K

Dec 17, 2025

Conviction: | View SEC Filing →
SELL Ceesay Abraham (Chief Executive Officer)

2,441 shares @ $28.84

$70K

Dec 17, 2025

Conviction: | View SEC Filing →
SELL Ceesay Abraham (Chief Executive Officer)

2,147 shares @ $28.84

$62K

Dec 17, 2025

Conviction: | View SEC Filing →
SELL Ceesay Abraham (Chief Executive Officer)

600 shares @ $31.04

$19K

Dec 17, 2025

Conviction: | View SEC Filing →
SELL Ceesay Abraham (Chief Executive Officer)

515 shares @ $31.04

$16K

Dec 17, 2025

Conviction: | View SEC Filing →
SELL Bredt David (Chief Scientific Officer)

7,704 shares @ $29.95

$231K

Dec 15, 2025

Conviction: | View SEC Filing →
SELL Bredt David (Chief Scientific Officer)

796 shares @ $30.68

$24K

Dec 15, 2025

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.